SABIC recently announced the official launch of its new US$170 (€157.7) million ultem resin manufacturing facility in Singapore, marking the company’s first advanced...

Evonik is reorganising two business lines to strengthen its growth prospects. The Coating & Adhesive Resins and Health Care Business Lines will concentrate on their...

German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to...

The Japanese technology group Asahi Kasei has moved the headquarters for its healthcare business from Japan to the US for strategic growth.

Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...

As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their...

As the discussion surrounding the high price of insulin in the US continues unabated, drugmaker Eli Lilly implemented price reductions of 70% for its most commonly...

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...